相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapy
Rieke Schroeder et al.
EPIGENETICS (2022)
DNMT1: A key drug target in triple-negative breast cancer
Kah Keng Wong
SEMINARS IN CANCER BIOLOGY (2021)
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Mei Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis
Xiaoti Lin et al.
MOLECULAR THERAPY (2021)
Long non-coding RNA SOX21-AS1 enhances the stemness of breast cancer cells via the Hippo pathway
Lanzhen Li et al.
FEBS OPEN BIO (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells
Nadia Flores-Huerta et al.
BIOMOLECULES (2021)
CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
Wei Huang et al.
ADVANCED SCIENCE (2021)
Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells
Jeong Hyun Shin et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
MicroRNAs, a Promising Target for Breast Cancer Stem Cells
Plabon Kumar Das et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Saioa Mendaza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
Shaoquan Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
DNA Modification Readers and Writers and Their Interplay
Cathia Rausch et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
Elisabet Cuyas et al.
AGING-US (2020)
microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2
Yuanwen Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency
Lena J. McLaughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer
Bin Bao et al.
MOLECULAR CANCER RESEARCH (2020)
Role of the CXCR4-LASP1 Axis in the Stabilization of Snail1 in Triple-Negative Breast Cancer
Boopathi Subramaniyan et al.
CANCERS (2020)
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
Sebastien Taurin et al.
NEOPLASIA (2020)
Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling
Binbin Wang et al.
MEDICAL SCIENCE MONITOR (2020)
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin et al.
ONCOGENE (2019)
Breast cancer stem cells: Biology and therapeutic implications
Ramesh Butti et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao et al.
EBIOMEDICINE (2019)
Long non-coding RNA FGF13-AS1 inhibits glycolysis and sternness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop
Fei Ma et al.
CANCER LETTERS (2019)
Methylation of C/EBPa by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer
Li-Ming Liu et al.
CANCER RESEARCH (2019)
Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells
Lingzhi Li et al.
SEMINARS IN CANCER BIOLOGY (2019)
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Sudha Suriyamurthy et al.
CANCERS (2019)
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway
Ang Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers
Zhenbo Tu et al.
STEM CELLS (2019)
SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
Jacob Batham et al.
CANCERS (2019)
The Histone Demethylase LSD1/KDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program
John Verigos et al.
CANCERS (2019)
Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications
Qi-Yuan Huang et al.
CANCERS (2019)
MicroRNAs Contribute to Breast Cancer Invasiveness
Ivana Fridrichova et al.
CELLS (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells
Meng Wang et al.
CELL PROLIFERATION (2019)
Microenvironment-regulated lncRNA-HAL is able to promote sternness in breast cancer cells
Alfredo Garcia-Venzor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy
Fatemeh Vahidian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway
Hui Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti et al.
CANCERS (2019)
SETDB1 regulates SMAD7 expression for breast cancer metastasis
Tae Young Ryu et al.
BMB REPORTS (2019)
Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer-Stem-Cell-like Phenotypic Traits in Triple-Negative Breast Cancers
Zhenbo Tu et al.
STEM CELLS (2019)
LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/beta-catenin Signaling
Tingting Tang et al.
THERANOSTICS (2019)
Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications
Maryam Zare et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Hee-Joo Choi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
H. Yamaguchi et al.
ONCOGENE (2018)
The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells
Katsuya Nakai et al.
BREAST CANCER (2018)
Long non-coding RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes in breast cancer cells
Linghuan Zeng et al.
ONCOLOGY LETTERS (2018)
The DNA methyl-transferase protein DNMT1 enhances tumor-promoting properties of breast stromal fibroblasts
Layla A. Al-Kharashi et al.
ONCOTARGET (2018)
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Hee-Joo Choi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness
Hidetaka Shima et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Zehua Wang et al.
CANCER CELL (2018)
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
Charly Ryan Good et al.
CANCER RESEARCH (2018)
MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7
Rui Liang et al.
CELL CYCLE (2018)
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
Alessandra di Gennaro et al.
CELL DEATH AND DIFFERENTIATION (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction
Feiyu Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking
Xin Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis
Zhi Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
Jia Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
Kirsten M. Tracy et al.
MOLECULAR CANCER RESEARCH (2018)
Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug
Nibedita Patel et al.
PLOS ONE (2018)
The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b
Khalid Sossey-Alaoui et al.
SCIENTIFIC REPORTS (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
Optimizing poly (ADP-ribose) polymerase inhibition through combined epigenetic and immunotherapy
Thiru Prasanna et al.
CANCER SCIENCE (2018)
The EZH2-H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells
Xiong Liu et al.
CELLULAR SIGNALLING (2018)
BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer
M. Janaki Ramaiah et al.
GENE (2018)
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Distinct expression profiles and functions of Kindlins in breast cancer
Paula Azorin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis
Guanming Lu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
Yanrong Su et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Breast Cancer Stem Cells
Judy S. Crabtree et al.
BIOMEDICINES (2018)
Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial-mesenchymal transition
Dan Du et al.
EMBO REPORTS (2018)
Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia
Gail J. Roboz et al.
CANCER (2018)
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer
Thehang Luu et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer
Hengyu Li et al.
MOLECULAR CARCINOGENESIS (2017)
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2017)
Epigenetic Silencing of miR-200c in Breast Cancer Is Associated With Aggressiveness and Is Modulated by ZEB1
Valentina Damiano et al.
GENES CHROMOSOMES & CANCER (2017)
Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer
L. Yu et al.
ONCOGENE (2017)
Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
A. E. Witt et al.
ONCOGENE (2017)
Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression
C. Cao et al.
ONCOGENE (2017)
Mechanism and biological role of Dnmt2 in Nucleic Acid Methylation
Albert Jeltsch et al.
RNA BIOLOGY (2017)
Targeting histone methylation for colorectal cancer
Tao Huang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Targeting breast cancer stem cells by novel HDAC3-selective inhibitors
Hao-Yu Hsieh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Emerging role of SETDB1 as a therapeutic target
Archana Venkataramana Karanth et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression
Irina V. Pronina et al.
GENE (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells
Mohammad Reza Alivand et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Epigenetics in cancer: Fundamentals and Beyond
Subhankar Biswas et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway
Jolene Caifeng Ho et al.
PLOS ONE (2017)
H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Fei Peng et al.
CELL DEATH & DISEASE (2017)
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
Cong Lv et al.
NATURE COMMUNICATIONS (2017)
Long non-coding RNA SOX21-AS1 modulates breast cancer stem cells properties and carcinogenesis via targeting SOX2
Zhen-Duo Lu et al.
Oncotarget (2017)
MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling
Fei Ma et al.
ONCOTARGET (2017)
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation
Mathangi Srinivasan et al.
ONCOTARGET (2017)
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Manuela Terranova-Barberio et al.
ONCOTARGET (2017)
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Rita El Helou et al.
CELL REPORTS (2017)
MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
Zhendong Shi et al.
JOURNAL OF CANCER (2017)
ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer
Takuya Hasegawa et al.
FEBS OPEN BIO (2017)
Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells
Jia Deng et al.
PLOS ONE (2017)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
Christos Damaskos et al.
ANTICANCER RESEARCH (2017)
KDM4 Inhibition Targets Breast Cancer Stem-like Cells
Eric Metzger et al.
CANCER RESEARCH (2017)
miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation
Bailong Li et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity
Elanor N. Wainwright et al.
TRENDS IN CANCER (2017)
Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
Geoffrey M. Wahl et al.
NPJ BREAST CANCER (2017)
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Bas J. Wouters et al.
BLOOD (2016)
Noncoding RNAs in breast cancer
Pang-Kuo Lo et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2016)
Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors
Muhammad Shaalan Beg et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling
Fei Jiang et al.
MOLECULAR CARCINOGENESIS (2016)
PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition
Z. Meng et al.
ONCOGENE (2016)
LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway
Mingli Zhou et al.
STEM CELLS (2016)
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
Giuseppina Roscigno et al.
ONCOTARGET (2016)
The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells
Zhiju Zhao et al.
PROTEIN & CELL (2016)
The specificity of long noncoding RNA expression
Brian S. Gloss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
Bailong Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Breast cancer stem cells programs: enter the (non)-code
Marion A. Salvador et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2016)
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer
Nidal E. Muvarak et al.
CANCER CELL (2016)
Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer
Hanlin Zeng et al.
CANCER CELL (2016)
Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells
X. Sun et al.
CANCER GENE THERAPY (2016)
Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells
Shinjiro Hino et al.
CANCER SCIENCE (2016)
Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity
Katarzyna Lubecka et al.
CARCINOGENESIS (2016)
miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation (vol 17, pg 648, 2016)
Ivan Bahena-Ocampo et al.
EMBO REPORTS (2016)
DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop
Dipta Sengupta et al.
EXPERIMENTAL CELL RESEARCH (2016)
Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition
Andrew Sulaiman et al.
FEBS LETTERS (2016)
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Yongcheng Song et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Novel miRNA genes hypermethylated in breast cancer
V. I. Loginov et al.
MOLECULAR BIOLOGY (2016)
Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
Guangcun Cheng et al.
MOLECULAR CANCER (2016)
Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model
Hui-Wen Chiu et al.
MOLECULAR CANCER (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Biomarkers for EMT and MET in breast cancer: An update
Fei Liu et al.
ONCOLOGY LETTERS (2016)
Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types
James D. Doecke et al.
CANCER GENETICS (2016)
Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
Xuejiao Song et al.
SCIENTIFIC REPORTS (2016)
The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
Yanyan Gao et al.
SCIENTIFIC REPORTS (2016)
Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model
Quan-Yi Zhao et al.
CLINICAL EPIGENETICS (2016)
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Ludovica Morera et al.
CLINICAL EPIGENETICS (2016)
miR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells
Lin Ma et al.
CANCER MEDICINE (2016)
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis
Eunsohl Lee et al.
NEOPLASIA (2016)
Role of EMT in Metastasis and Therapy Resistance
Bethany N. Smith et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression
Yi Pan et al.
SCIENTIFIC REPORTS (2016)
Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis
Cecilia Arana Yi et al.
FUTURE ONCOLOGY (2015)
The landscape of long noncoding RNAs in the human transcriptome
Matthew K. Iyer et al.
NATURE GENETICS (2015)
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C. U. Cheang et al.
ONCOLOGIST (2015)
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Clare Stirzaker et al.
NATURE COMMUNICATIONS (2015)
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis
Rajneesh Pathania et al.
NATURE COMMUNICATIONS (2015)
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
Francesca Collina et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo
Yuan Li et al.
FEBS OPEN BIO (2015)
Functional role of G9a histone methyltransferase in cancer
Francesco Casciello et al.
FRONTIERS IN IMMUNOLOGY (2015)
The Regulatory Role of MicroRNAs in EMT and Cancer
Apostolos Zaravinos
JOURNAL OF ONCOLOGY (2015)
Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
Patompon Wongtrakoongate
WORLD JOURNAL OF STEM CELLS (2015)
LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
Satoi Nagasawa et al.
PLOS ONE (2015)
δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells
Akihiko Fukagawa et al.
CANCER MEDICINE (2015)
Oncofetal H19 RNA promotes tumor metastasis
Imad J. Matouk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
Anurag N. Paranjape et al.
BMC CANCER (2014)
Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer
Xu Han et al.
CANCER GENE THERAPY (2014)
MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer
Mei-Yi Wu et al.
CANCER LETTERS (2014)
Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem-like Cell Traits in Breast Cancer
Man-Li Luo et al.
CANCER RESEARCH (2014)
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions
Hao Wu et al.
CELL (2014)
The de novo DNA methyltransferase DNMT3A in development and cancer
Bi-Feng Chen et al.
EPIGENETICS (2014)
Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer
Marjan E. Askarian-Amiri et al.
PLOS ONE (2014)
EZH2 expands breast stem cells through activation of NOTCH1 signaling
Maria E. Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome
Rita El Helou et al.
STEM CELLS (2014)
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
Dong Soon Choi et al.
STEM CELLS (2014)
MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway
Hongyi Zhang et al.
STEM CELLS (2014)
New concepts in DNA methylation
Albert Jeltsch et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Swayamsiddha Kar et al.
CLINICAL EPIGENETICS (2014)
The role of nnicroRNAs in the regulation of cancer stem cells
Ryou-u Takahashi et al.
FRONTIERS IN GENETICS (2014)
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
Kirstin Lund et al.
GENOME BIOLOGY (2014)
Genome-Wide Epigenetic Regulation of miRNAs in Cancer
Constance Baer et al.
CANCER RESEARCH (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
DNA methylation: roles in mammalian development
Zachary D. Smith et al.
NATURE REVIEWS GENETICS (2013)
Let-7: A regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells
Xin Sun et al.
ONCOLOGY REPORTS (2013)
BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling
Hifzur Rahman Siddique et al.
PLOS ONE (2013)
A Bmi1-miRNAs Cross-Talk Modulates Chemotherapy Response to 5-Fluorouracil in Breast Cancer Cells
Jiang Yin et al.
PLOS ONE (2013)
Brief Report: The lincRNA Hotair Is Required for Epithelial-to-Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines
Cleidson Padua Alves et al.
STEM CELLS (2013)
EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
Lilian E. van Vlerken et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Molecular Pathology of Breast Cancer What a Pathologist Needs to Know
Kimberly H. Allison
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells
Qingsong Zhu et al.
AMINO ACIDS (2012)
Epigenetic Events Associated with Breast Cancer and Their Prevention by Dietary Components Targeting the Epigenome
Shabana I. Khan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Silencing of Wnt5a during colon cancer metastasis involves histone modifications
Qian Li et al.
EPIGENETICS (2012)
Estrogen Receptor α Signaling Regulates Breast Tumor-initiating Cells by Down-regulating miR-140 Which Targets the Transcription Factor SOX2
Yongshu Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
Chenfang Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Defining the mode of tumour growth by clonal analysis
Gregory Driessens et al.
NATURE (2012)
Defining the cellular precursors to human breast cancer
Patricia J. Keller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer stem cells and metastasis
Katia Sampieri et al.
SEMINARS IN CANCER BIOLOGY (2012)
DNA methylation signatures for breast cancer classification and prognosis
Moshe Szyf
GENOME MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Theresa A. Proia et al.
CELL STEM CELL (2011)
Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family
Lars Hillringhaus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
Bao-Hong Guo et al.
MOLECULAR CANCER (2011)
Epigenetic Regulation of Cell Type-Specific Expression Patterns in the Human Mammary Epithelium
Reo Maruyama et al.
PLOS GENETICS (2011)
DNA methyltransferases and methyl-binding proteins of mammals
Jie Lan et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
The H19 locus: Role of an imprinted non-coding RNA in growth and development
Anne Gabory et al.
BIOESSAYS (2010)
Histological, molecular and functional subtypes of breast cancers
Gautam K. Malhotra et al.
CANCER BIOLOGY & THERAPY (2010)
Cross-talk between miRNA and Notch signaling pathways in tumor development and progression
Zhiwei Wang et al.
CANCER LETTERS (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Breast Cancer Stem Cells: Something Out of Notching?
Hannah Harrison et al.
CANCER RESEARCH (2010)
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
Soyoung Lim et al.
CARCINOGENESIS (2010)
TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine
Haikuo Zhang et al.
CELL RESEARCH (2010)
Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Y. Li et al.
CURRENT MEDICINAL CHEMISTRY (2010)
G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53
Jing Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
Tony Blick et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Epigenetic modifications as therapeutic targets
Theresa K. Kelly et al.
NATURE BIOTECHNOLOGY (2010)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Timothy Hoey et al.
CELL STEM CELL (2009)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
EPIGENETIC TARGETING IN BREAST CANCER: THERAPEUTIC IMPACT AND FUTURE DIRECTION
M. B. Lustberg et al.
DRUG NEWS & PERSPECTIVES (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Genetics and epigenetics: stability and plasticity during cellular differentiation
Fabio Mohn et al.
TRENDS IN GENETICS (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs
John L. Rinn et al.
CELL (2007)
Heterochromatin revisited
Shiv I. S. Grewal et al.
NATURE REVIEWS GENETICS (2007)
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters
S Saxonov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Stem colls and cancer: The polycomb connection
ME Valk-Lingbeek et al.
CELL (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor
L Yang et al.
ONCOGENE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
